Optimism Around North Chemical Industries (SZSE:002246) Delivering New Earnings Growth May Be Shrinking as Stock Declines 8.7% This Past Week
Optimism Around North Chemical Industries (SZSE:002246) Delivering New Earnings Growth May Be Shrinking as Stock Declines 8.7% This Past Week
You can invest in an index fund if you want to make sure your returns approximately match the overall market. In contrast individual stocks will provide a wide range of possible returns, and may fall short. For example, the North Chemical Industries Co., Ltd. (SZSE:002246) share price fell 19% in the last year, slightly below the market decline of around 17%. On the bright side, the stock is actually up 1.2% in the last three years. The last month has also been disappointing, with the stock slipping a further 24%.
如果您希望確保回報大致符合整體市場水平,您可以投資於指數基金。相比之下,個別股票會提供各種可能的回報範圍,但有可能會表現不佳。例如,北化股份(SZSE:002246)股價在過去一年中下跌了19%,略低於市場下跌約17%的水平。但好消息是,在過去的三年中,該股票實際上上漲了1.2%。最近一個月也令人失望,股票下跌了進一步的24%。
After losing 8.7% this past week, it's worth investigating the company's fundamentals to see what we can infer from past performance.
在過去的一週中下跌了8.7%,值得調查該公司的基本面以了解過去的表現可以推斷出什麼。
We don't think that North Chemical Industries' modest trailing twelve month profit has the market's full attention at the moment. We think revenue is probably a better guide. Generally speaking, we'd consider a stock like this alongside loss-making companies, simply because the quantum of the profit is so low. It would be hard to believe in a more profitable future without growing revenues.
我們認爲,北化股份近12個月平均利潤並沒有完全得到市場的關注。我們認爲,營業收入可能是更好的指標。一般來說,我們會將這樣的股票與虧損的公司放在一起考慮,僅因爲利潤數量如此之低。沒有增長的營業收入,很難相信未來會有更多利潤。
In just one year North Chemical Industries saw its revenue fall by 14%. That looks pretty grim, at a glance. The stock price has languished lately, falling 19% in a year. What would you expect when revenue is falling, and it doesn't make a profit? It's hard to escape the conclusion that buyers must envision either growth down the track, cost cutting, or both.
在短短一年之內,北化股份的營業收入下降了14%。乍一看,情況相當嚴峻。股票價格最近一直低迷,一年下跌了19%。當營業收入下降且沒有盈利時,你會預期什麼?很難逃脫的結論是,買家必須預見到未來的增長、成本削減或兩者兼備。
You can see how earnings and revenue have changed over time in the image below (click on the chart to see the exact values).
你可以在下面的圖片中看到收入和營業收入隨時間的變化情況(單擊圖表可查看精確值)。
![big](https://usnewsfile.moomoo.com/public/MM-PersistNewsContentImage/7781/20240719/0-8cf7f76760c583a299c781959435345b-0-e88c55ea83be99ae352f29e05835fa49.png/big)
You can see how its balance sheet has strengthened (or weakened) over time in this free interactive graphic.
你可以在這個免費的互動圖表中看到它的資產負債表如何隨着時間的推移而加強(或削弱)。
A Different Perspective
不同的觀點
We regret to report that North Chemical Industries shareholders are down 19% for the year (even including dividends). Unfortunately, that's worse than the broader market decline of 17%. Having said that, it's inevitable that some stocks will be oversold in a falling market. The key is to keep your eyes on the fundamental developments. Regrettably, last year's performance caps off a bad run, with the shareholders facing a total loss of 1.4% per year over five years. We realise that Baron Rothschild has said investors should "buy when there is blood on the streets", but we caution that investors should first be sure they are buying a high quality business. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. Like risks, for instance. Every company has them, and we've spotted 4 warning signs for North Chemical Industries (of which 2 shouldn't be ignored!) you should know about.
遺憾的是,北化股份的股東在今年下跌了19%(包括分紅派息)。不幸的是,這比整體市場下跌17%更糟糕。話雖如此,在下跌的市場中,一些股票不可避免地會被超賣。關鍵是要關注基本面的發展。遺憾的是,去年的表現爲股東帶來了糟糕的結果,五年來的總損失達到每年1.4%。我們意識到,羅斯柴爾德男爵曾說過,在市場血流成河時應該“買進”。但我們警告說,投資者應該先確定他們購買的是高質量的業務。我認爲,長期的股票價格可以作爲業績的代理,很有趣。但是,要真正獲得洞察力,我們需要考慮其他信息。例如,風險。每個公司都有風險,我們已經發現北化股份存在4個警告信號(其中2個不應該被忽視!)您應該知道。
For those who like to find winning investments this free list of undervalued companies with recent insider purchasing, could be just the ticket.
對於那些喜歡尋找獲勝投資的人來說,最近有內部購買的低估公司免費列表可能是一個很好的選擇。
Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Chinese exchanges.
請注意,本文引用的市場回報反映了目前在中國交易所上市的股票的市場加權平均回報。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
對本文有任何反饋?對內容有任何疑慮?請直接與我們聯繫。或者,發送電子郵件至editorial-team@simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論,只使用公正的方法論,我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議,也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
對本文有任何反饋?對內容有任何疑慮?請直接與我們聯繫。或者,發送電子郵件至editorial-team@simplywallst.com。